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                                       ABSTRACT 
Background: 
                          Rodenticide  poisoning, the second most common poisoning in 
our area. Three types of rodenticides are available in our area, namely 
phosphorus compound ( ratol paste), zinc phosphide(powder), 
superwarfarin(bait). Among these compounds, phosphorus causes death in 
patients. Since only limited studies are available about rodenticide poisoning in 
India, this study was done, about the clinical profile of patients admitted with 
this type of poisoning and correlating various parameters with the mortality. 
Methods: 
                          This was cross-sectional study done at Thanjavur medical 
college hospital, Thanjavur, conducted among 60 patients , admitted with 
alleged history of ingesting rodenticides in past 24 hours before admission, 
satisfying inclusion and exclusion criteria. Detailed history, examination with 
laboratory parameters such as serum bilirubin on admission, after 4th day and 
afterwards, INR value, SGPT, serum creatinine was estimated and they are 
correlated with the mortality of the patients. The results being analysed with 
chi-square and ANOVA test. 
 
 
Results: 
                            In this study, mortality was 20%, all due to phosphorus 
compound. Most common age group of 20-30 years,mostly from poor 
socioeconomic status. 70% ingested phosphorus compound, 18.3% ingested 
phosphide and 11.7% ingested super warfarin compounds. Mortality was higher 
in delayed hospitalisation. Abdominal pain was the most common symptom and 
jaundice observed on 4th day of admission after ingesting phosphorus. 
                               No significant association with age, sex, socio-economic 
status, marital status, abdominal pain and bleeding manifestations. But there 
was significant correlation with quality of compound, time delay, jaundice, 
oliguria, serum bilirubin, SGPT and serum creatinine level with mortality. 
Conclusion: 
                              Mortality was common in phosphorus compound , who 
developed jaundice on 4th day of admission following acute hepatotoxicity 
reflected by elevated bilirubin, SGPT values and hence considered as deadliest 
compound and can be banned , having lethal dose of less than 1mg/kg.  Further 
early administration of N-acetyl cysteine is recommended. 
Key words; 
                                Rodenticides, yellow phosphorus compound, N-acetyl 
cysteine.                         
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INTRODUCTION:- 
                                 Poisoning is mostly preventable, commonly suicidal 
and rarely being accidental form of death in developing agrarian 
countries. In rural India, poisoning forms the major share of emergency 
health care and of about one – fourth to one – third of intensive care 
admissions. 
                               Among poisoning, in our region, next to organo- 
phosphorus poisoning, rat killer or rodenticide poisoning remains the 
second most common ingested poison. 
                                However as compared to organophosphorus 
poisoning, there are only few literatures available for rodenticide 
poisoning.  Almost every system is affected in rodenticide poisoning and 
also there is no definite treatment guidelines available .Regarding it’s 
incidence, mode of action and management, only few studies are 
available. Further there is no positive clinical trials available regarding 
phosphorus paste poisoning , which remains the deadliest among 
rodenticide poisons. 
                                 Rodenticides are commonly available in almost 
every household, to prevent their stored grains from rodents, which is 
found everywhere.  Since it is easily available and also cheaper than other 
1 
pesticides in the markets. Because of its easy availability in every house , 
it is often taken with suicidal indent or ingested accidentally by children. 
                                     Rodenticide is available in three different forms in 
our area, as follows – 
  1) Powder form     -   zinc phosphide 
   2) Paste form       -   yellow phosphorus 
   3) Bait form         -   super warfarins 
                                     Among these rodenticides , phosphorus being the 
most commonly and also most lethal poison , especially after 3-4 days of 
ingestion , as liver injury sets in. Since there is no sufficient datas 
available regarding rodenticides , I prefer to perform this study regarding 
its clinical profile.  
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AIMS AND OBJECTIVES:- 
1) To study the clinical profile of patients admitted with 
rodenticide poisoning and their course in the hospital. 
2) To correlate various parameters with the mortality.  
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                                     REVIEW OF LITERATURE 
  
RODENTICIDE POISONING 
                             There was competition between humans and rodents for 
food since past. Due to his super brain, human developed some agents to 
kill the rodents. Rodenticides are produced in such a way to kill the 
rodents , which damage the crops in field , stored grains in godowns, bite 
peoples and also capable of spreading deadly diseases such as plague(1,2). 
                           It includes variety of chemicals with various actions, 
which may be organic or inorganic, may be mild or highly toxic, but they 
kill them in a cost effective manner. Now the problem arise, because 
humans either accidentally or intentionally ingest these chemicals. 
                              In earlier days rodenticides, were mainly made from 
plant such as strychnine or inorganic chemicals as thallium and arsenic 
trioxide .Now, they are manufactured from synthetic organic compounds 
                             Some agents such as thallium are as dangerous to 
human as rodents. However  their  use being restricted nowadays to 
lessen the risk of toxicity in humans especially. But still, they are 
regarded as toxic, if they are misused.. 
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                                  Rodenticide is a product, which is available in the 
market, use to kill rodents, mice and other small animals.  
                                   
 Perfect rodenticide is a one as suggested (1,3)  , “ that effectively kills 
rodents , but is not toxic to humans or non- rodent pet” , which is yet to 
be discovered or synthesized . 
                                   However, now, a large group of less than perfect 
rodenticides are available in markets, which differs from each other in 
chemical composition and mode of action and its toxicity to humans. 
                                  Rodenticides are classified (4)  in several ways as 
1.) Inorganic or organic compounds 
2.) Animal selectivity 
3.) Nature and onset of symptoms and 
4.) LD 50 in rats 
 
                                     Of these compounds; zinc phosphide and 
phosphorus comes under highly toxic compound, while 
superwarfarin being a low toxic compound. 
                               Since zinc phosphide is available in most diluted 
form in market, toxicity is comparatively less. 
5 
                               Let now see the three individual compound in 
detail. 
 
  
PHOSPHORUS 
                                It is derived from greek word PHOS:- meaning 
light ; PHORUS :- meaning bringing .  
    
                             It was first identified in urine by chemist 
HENNING BRANT in hamburg in 1669. The early use of 
phosphorus was in 1720 in medical books. It was used for colic, 
tetanus, gout and apoplexy. It was popular as tonic aphrodisiac, 
impressing on looker of its phosphorescent and explosive nature. 
Inspite of its toxicity, it was found in British pharmacopedia till 
1932.  
                              White phosphorus gained importance, since it 
was used as main ingredients in lucifiers or in match industry. It was 
invented  by chemist Charles sauria of paris in 1830. It was mainly 
used in match industry. After some years it was banned world wide 
as of using in striking pad. On the match box, and now red 
phosphorus has replaced it, in striking pad as well as match head. 
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                              White phosphorus is now used to manufacture, 
insecticide, fertilizer as phosphoric acid and homemade wirework (5) 
which contain about 10% phosphorus.  
       Phosphorus in 15th element in table, it exist in 3 forms 
i) black phosphorus  →non toxic, not ignite spontaneously 
ii) red phosphorus  →faily innocuous→ intermediate reactivity 
iii) white phosphorus →highly reactive and dangerous 
compound. 
                        White  phosphorus in tetramer (D4), water insoluble, 
a waxy paste. It emit pale green glow, due to low reactivity with 
oxygen. Impurities in white phosphorus make it as yellow 
phosphorus.   
                           Phosphorus on combining with oxygen, gives  
Phosphorus oxide with liberation of light and dense smoke with 
Garlic odour, On dissolving with water, it produces phosphoric 
acid. 
                                                  It is rapidly absorbed and distributed primarily in 
               the liver, kidney, intestinal mucosa, epidermis, follicles and pancreas         
                            Other tissues such as lung, myocardium, spleen 
and renal medulla of moderate distribution  , brain fat and muscle of 
low distribution(7). 
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                          In rats, sub-cutaneous lethal dose in 10mg /kg(8) 
while in human studies suggest lethal dose as 50mg or 1mg/kg.(9). It 
is highly lipid solubility, high absorption occur after skin or mucosal 
exposure. 
 
CLINICAL MANIFESTASIONS: 
                    Mortality due to ingestion, range from 20 to 50% (10,11) 
Indicators of poor prognosis (12) 
i) ingestion of more  than 1mg/kg  
ii) severe electrolyte disturbance 
iii) mental status changes 
                       prolongation of Q-T interval 
iv) more than 10 fold raise in alanine amino transferase 
v)  severe coagulopathy 
vi)
 peak liver enzymes reached within three days of 
ingestion 
                          Old literature, describes course of poisoning in 3 
stages (13) 
                                            i) lasts- hours to days after ingestion 
manifested as irritation of digestive tracts, may cause arrhythmias 
and same neurological manifestations. 
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                                             ii)II stage: digestive symptoms resolve, 
lasting for few days  
                                               iii) patients develop hepatic, renal and 
cardiac toxicities, mostly causing death. If recovery occurs, it takes 
few weeks 
                              However most death occurs as result of fulminant 
hepatic failure within first week. Some delayed death occurs 
between 5-8 days due to cardiotoxic. Few deaths only occurs,if 
patient survive beyond this stage. 
 
HEPATIC: 
                                   It produces hepatotoxicity in dose dependent 
manner (14). Amino transferase rises in half of ingested patients, 
mostly begin to rise within one day of exposure. Time of enzyme 
peak and level rise differ significantly between patient who survives 
and who dies. 
   
                                  
          Patients who dies have average peak of sixteen 
times of normal, reached in 2-3 days. In those who survives, alanine 
aminotransferase (SGOT) rises eight times normal,  reaching peak in 
six days . 
                  
                                 Coagulopathy in 20 % of patients (5) 
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    Serum triglyceride level fall as toxicity develops, 
there may be also increase in serum and urinary ketones 
                               It consumes oxygen in liver cells , is a  
protoplasmic poison which uncouples oxidative phosphorylation , in 
turns leads to decrease in intrahepatocyte ATP levels(8)    
                                            
      It also affects transition of triglyceride as beta-
lipoproteins. Massive hepatic steatosis, hallmark of white 
phosphorus toxicity,  rise in triglyceride level in two hours , peaking 
in two days . Hepatic necrosis is particularly in zone 1 , distinct 
from acetaminophen and carbon tetrachloride , hepatic glycogen are 
decreased due to increased glucose-6- phosphatase activity .  
                             A non specific finding of huge increase in rough 
endoplasmic reticulum, is typically found in this poison (17,18 ) 
                              Liver biopsy showed signs of acute hepatocellular 
necrosis also showing fibrosis and piecemeal necrosis 
SKIN, MUCOSA AND GASTROINTESTINAL TRACT:- 
                              Burns produced by this poison is extremely 
painful with characteristic garlic odour, yellow colour and necrotic 
base. it heals slowly like other chemical burns , and also require 
prolonged hospital stay(19,20)     , which may be of second degree or 
third degree burns involving 15% of body surface area , may result 
in death(12)  ,due to absorption of phosphorus . 
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                               Mucosal erosions were also noted, when it get 
exposed to mouth, eyes, it may show bullae , injection. 
                                Thus following intake of phosphorus, it may 
shows oral burns, vomiting, loose stools, abdominal pain and even 
bleeding, as haematamesis. the vomitus and stool show typical 
garlic odour , and it also appear as glistening in dark room , hence it 
is also mentioned as   SMOKING STOOL SYNDROME .(19)    
                                  The main mechanism being exothermic 
reaction . If it penetrates dermis, causes tissue damage, due to 
production of phosphoric acid, when reacting with oxygen. 
Digestive system is less involved than skin, probably due to low 
oxygen concentration. Severe mucosal involvement is also 
explained due to generation of phosphoric acid. 
CARDIOVASCULAR SYSTEM :- 
                                        Early death within twenty four hours, after 
intake of phosphorus is mainly due to cardiovascular collapse  
                                    Electrocardiograph taken during interval 
hours of admission may reveal. QT prolongation, atrial fibrillation, 
ST depression, which may be due to electrolyte deficiency, mainly 
of calcium.(20,21). Cardiac arrest also occurs, after few hours of even 
dermal exposure, it generally occurs 4-10 hours after absorption. 
Cardiac arrest without any rhythm disturbances or myocardial injury 
11 
are also reported. hypo calcemia also causes cardiomyopathy and 
mimics like myocardial infarction.(22,23) 
                                  Usually there are no morphological changes, 
however intestinal edema and vacuolated cytoplasm urine noted. 
   
NERVOUS SYSTEM: 
                                  It produces neurological manifestation such as 
anxiety, confusion, irritability, hallucination, epilepsy, loss of 
consciousness and deep coma. If any patient is found to have 
neurological findings initially before involvement of other systems, 
had increased mortality of 20%(13).hypocalcemia can produce 
carpopedal spasm, paraesthesia, tetany or laryngeal stridor(25) 
                            However, neural uptake of phosphorus is only 
small quantity (7), there was also no distinct histological change in 
the brain. Thus neurological manifestation was mainly due to 
hypocalcemia, rather than due to direct effect of phosphorus. 
RENAL: 
                                 Half of the cases, have showed increase urea 
and creatinine values, but only few developed chronic kidney 
disease (27).Rarely acute tubular necrosis also noted. 
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                               It mainly causes glomerular injury after 
absorption in GIT, histological finding shows fatty degeneration in 
few cases and fatty deposition with necrotic changes in some. 
ELECTROLYTE DISTURBANCES: 
                                   Due to absorption of phosphorus and into 
conversion to phosphoric acid, some deproteination, 
hyperphosphatemia was noted. Calcium forms calcium phosphates 
salts which lead on to hypocalcemia. Hyperkalemia was noted, due 
to hypocalcemia or due to renal failure.  
CHRONIC EXPOSURE: 
                             It leads to mandibular osteonecrosis described as 
PHASSY JAW and also extreme fatigue and anaemia. 
DIFFERENTIAL DIAGNOSIS :- 
                              Unknown rodenticide exposure may be identified 
by few findings 
                             Rapid action poisons, may manifests symptoms 
within six hours, if it shows more cholinergic findings, it suggests 
organophosphorus poisoning. More muscular activity suggests 
strychnine poisoning 
                               More gastrointestinal symptoms such as mucosal 
burns, vomiting, abdominal pain and loose stools, suggests yellow 
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phosphorus poisoning. If it shows respiratory symptoms suggests 
zinc phosphide. 
                                    Delayed poisoning, manifests usually after 
twelve hours, most commonly due to superwarfarin groups (26) 
                                  The smell also shows some clue such as 
phosphorus smell as garlic; while zinc and aluminium phosphide 
smell as rotten fish, due to liberation of phosphine gas as it 
combines with air or water. 
HEALTH CARE AWARENESS 
 
                                 Vomitus or stool containing white phosphorus 
is extremely dangerous, hence utmost care should be taken, to 
prevent toxicity to health care workers. 
                               Few cases have also been reported, when these 
health care workers comes in contact with patient’s stool or 
vomitus(27) . 
                                 Due to low melting point of phosphorus, it may 
present in clothes and other materials in liquid state and it may 
ignite at normal room temperature (28) .  
                                   Hence health care workers are advised to wear 
protective dress, in order to prevent them from contact with poison. 
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MANAGEMENT 
          INTIAL CARE:- 
                                    Basic life support such as protection of 
airway and circulatory status must be maintained. 
                                     Complete blood count , liver function test , 
prothrombin time , international standardised ratio ( INR ) , blood 
urea , serum creatinine , serum electrolytes especially of calcium 
phosphates , potassium should be done immediately after admission,  
On  accessing intravenous line, 
                               Frequent recording of vitals and cardiac 
monitoring should be done. Urine output should be recorded , if they 
complaint of irritation of eye , eye wash should be given with clean 
water immediately .  
DECONTAMINATION OF SKIN:- 
                                Patient with dermal exposure to poison should 
be immediately cleaned or immersed in water, it will reduce the 
wound size and hence reduce the hospital stay and also significantly 
reduce the death (29) . 
                               Any region in skin which comes in contact with 
phosphorus, must be kept wet; to prevent ignition, if it gets contact 
with room oxygen (28) . 
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                               Copper sulphate solutions, which are usually 
used convert phosphorus element to less harmful – copper 
phosphate, which is black in colour and was easily removed from 
skin and clothes. But copper sulphate inhibits glucose – 6 – 
phosphate dehydrogenase enzyme, which may lead on to 
haemolysis,  which turns on to be of worse prognosis (26)  . It may 
also be identified by wood lamp examination, by fluorescent nature 
of phosphorus. 
                                  However by applying silver nitrate, it prevents 
phosphorus getting ignited by forming a protective silver layer over 
phosphorus (30) . After preventing ignition and identifying 
phosphorus, a through debridement of skin was done, since 
remaining poison may be prove to be toxic. 
DECONTAMINATION OF DIGESTIVE TRACT:- 
                                       Early gastric lavage was indicated (31) . Due 
to high toxicity of phosphorus and since no specific antidote is 
available, lavage should be done in all patients. However utmost 
care must be taken, since explosion may occur following contact 
with oxygen, after inserting ryle’s tube (8) . This may also be 
prevented by placing syringe filled with water at nasal end of the 
tube,after conforming the position of the tube , water is being 
instilled , instead of air . 
16 
                                      However there are no datas available 
regarding supportive use of charcoal for adsorbing phosphorus , 
since due to it’s high toxic nature and no oesophageal burns is 
getting reported , activated charcoal is being administered widely in 
many centres.  
                                        Bowel wash with polyethylene glycol is 
tried, since it forms non-absorbable material and thus getting 
washed away with stool (31) 
                                                   Potassium permanganate wash will convert 
phosphorus to least toxic oxide (32) .  Nowadays it is used worldwide,  but 
anyway there was no positive results. It is not easily available and huge risk, it 
was not indicated. 
    TREATMENT: 
                                                No specific antidote is available up to date.  But 
n-acetyl cysteine regimen have prevented death in significant number of patient, 
if it was administered early, if it was continued in full course. Since there is no 
potential side effect, no detailed study is available, if it is recommened to use in 
white phosphorus poisoning. 
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OTHER MODALITIES: 
                                             Steroids was not useful in preventing 
hepatotoxicity. In ubiquinone and sulphate were preventing liver toxicity to 
some extent, no human study is available yet (15). 
HAEMODIALYSIS: 
                                                Haemodialysis rapidly correct the electrolyte 
disturbances such as hyperphosphatemia, hyperkalemia and hypocalcemia; but 
no report was available. However it significantly reduces mortality by 50%, 
thus exchange transfusion was beneficial.(10,14). 
  
PHOSPHIDES: 
                                                  Phosphides such as zinc and aluminium are 
being used as rodenticides in developing countries to protect grains from 
rodents (33), because it is cheaper and effective. Zinc phosphide is dark gray in 
colour, has rotten fish odour and bad taste, hence it was not used by other 
animals except rats. When mixed with tartar emetic, both these phosphides, 
release phosphine gas readily, when it comes in contact with water or diluted 
acids (33). 
                                                      The exact mechanism is not clear. Phosphine 
is produced after phosphide reacts with hydrochloric acid in stomach. It inhibits 
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cytochrome-C oxidase and in turn inhibits oxidative phosphorylation of electron 
transport system (34), which in turn leads to various cellular toxicity, necrosis of 
gastrointestinal tract, liver and also kidneys. phosphine, being heavier than air, 
having rotten fish odour, can be detected even at levels of 2 ppm.(34) Typical 
odour can not be as warning sign, since toxicity occur even below the level of 
olfactory threshold. More number of oral exposures had been reported. It was 
also identified as one of the most common suicidal agent in India (35). 
                                                         The exact level of lethal dose is not known 
since it was reported that even after ingesting a small amount of 5gm, the 
patient has died. Some patients have survived even after ingesting 50gm. 
Inhalation of toxic exposure of phosphine is also reported.  
                                                     It causes severe mucosal irritation, manifested 
as nausea, vomiting and abdominal pain with in 15 minutes of ingestion of 
aluminium phosphide and 30minutes after ingestion zinc phosphide(35) 
                                                    Other symptoms being hypotension, 
palpitation, acidosis, tetany. Systemic toxic symptoms such as broad QRS 
complex, jaundice and pulmonary edema is also reported. However 
neurological manifestations are rare, but seizures and coma are recorded in 
expired patients(36). Majority of death occurs after 24 hours of ingestion, may be 
delayed upto 2 weeks, which was mainly reported due to myocardial damage 
(35)
. 
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                                                     Long term exposure in industry may reduce 
psychiatric, pulmonary, hepatic and cardiac findings. 
MANAGEMENT: 
                                                     Treatment is mainly supportive and also 
symptomatic. If there is acute ingestion, activated charcoal is useful, however 
patient should be continously monitor. Liver function test, urea, creatinine, 
electrolytes should be measured. After lavage, phosphine gas is emitted in 
lavage solution and stools,  hence they must be cleaned and disposed properly to 
prevent inhalation exposure to health care workers by providing proper face 
masks.  
                                                        Lavage are tried using sodium bicarbonate, 
plain water or even milk. Administration of proton pump inhibitor with antacid 
is useful. But prognosis is worse, if pulmonary and cardiovascular 
manifestations arise early. Chest x-ray for identifying pulmonary toxicity and 
abdominal x-ray for opacities in gut may help. 
 ANTI- COAGULANTS:    
                                                         Warfarin and super warfarins belongs to this 
class of poison. Toxicity due to anticoagulants in both human and rodent are 
rare, it may require repeated exposure at small doses. No toxicity is reported in 
humans after single exposure. It was also least effective in rodents. Hence they 
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were considered as safe, but they are discarded as poor rodenticides. It leads to 
many resistant rats in few regions. 
                                                         In 1980, however newer anticoagulants such 
as indanediones and hydroxy coumarins are produced. These are potent long 
acting, called “super warfarin”,  produced significant anticoagulant effect for 6 
weeks, even after single. Thus now it becomes one of deadliest toxin. It mostly 
occurs in children as accidental exposure (37) 
MODE OF ACTION: 
                                                    As warfarin is a known anti metabolite of 
vitamin k they inhibit synthesis of vitamin k dependent coagulation factors , 
namely ii ,vii , ix and x , by preventing the conversion of inactive vitamin K ( 
epoxide )to its active form ( quinol ) . however repeated doses are required , 
which maintain maximum inhibition of active vitamin K synthesis , which 
results in elevated prothrombin levels , resulting in depletion of vitamin K 
dependent clotting factors and causes haemorrhage throughout the body , which 
may result in death . Bleeding occurs only if factors level, decreases more than 
one fourth of baseline level.  
                                                 Since factor vii have short half life – 5 hours , 
rise in prothrombin time is seen in low half live – 20 hours , and will be rised 
till two days(37)    
21 
                                   In addition, it also cause direct capillary damage, which 
leads to further bleed. 
                                 Initial test to be done are 
                1 ) prothrombin time, 
                2) International Normalised Ratio (INR ) 
                3) complete blood count 
               4 ) liver function test  
                5) serum fibrinogen  
                 
                6 ) measurement of vitamin K dependent coagulation factors  
                                           ( ii , vii , viii , ix , x ) 
CLINICAL PRESENTATION:- 
                                        Patient is asymptomatic, immediately after ingesting 
poison, but develops symptoms 1 – 2 days after ingestion. They manifest 
various forms of bleeding manifestations in following orders of frequency as 
ecchymosis , haematuria , gynaecological bleeding , gastrointestinal bleeding , 
nasal bleed , haematoma , gum bleed . 
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                                     However detailed investigations including prothrombin 
time, INR, blood count and even assessment of clotting factors such as ii and vii 
is useful. It is essential to measure this laboratory values, in helping to identify 
chronic ingestion of anticoagulants (38)  . 
                                    Differential diagnosis being haemophilia, vitamin K 
deficiency, disseminated intravascular coagulation (DIC) and other factors 
deficiencies, other cause of liver failure must also be ruled out. In developed 
countries, measurement of newer agents level in blood as difenacoum is 
performed. 
MANAGEMENT  :- 
                                        It depends on time of presentation, amount ingested 
and bleeding manifestations. Acute intake of less than one bait of super warfarin 
does not produce significant toxicity and they are simply managed. Without 
gastric lavage and no lab investigations is needed; unless bleeding occurs. 
                                    If they ingest more than one bait, and present within four 
hours of ingestion, activated charcoal is administered.  
                               Repeated administration of oral adsorbents such as 
cholestyramine , not only prevents absorption , but also reduces the half life of 
already absorbed anticoagulants. 
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                               Acute bleeding episodes are managed with crystalloids to 
replenish blood loss. Patients presenting with severe active bleeding are given 
fresh frozen plasma. 
                                   However, vitamin K (10mg) intravenously is given for 
adults. prophylactically, its action manifest only after 24 hours. It must be 
administered at less than 1mg/minute to reduce anaphylaxis. Repeated doses 
may be needed, which depends amounts and specificity of the compound. 
Prothrombin time should be monitor to evaluate if future treatment is needed.  
                                      A normal PT after two days excludes major 
anticoagulants activity (39). 
                                     All bleeding patients should be admitted to central 
bleeding, and patients with severe bleeding needs intensive care monitoring. 
                                      Asymptomatic patients are discharged immediately and 
follow up INR is carried out at 24 and 48 hours respectively. 
                                        All vitamin K preparations are not effective, 
phytonadione(vitamin K1) is used for this purpose. The needed dose, duration 
of treatment varies widely with amount and type of poison taken and also 
patient metabolism. 
                                        Taking serial measurements of toxin level, determines 
duration of treatment needed. 
24 
                                        Maximum dose of 100mg in a day for upto 10 months 
is being used in huge bleeding (39).                                               
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Now, let us see about the other compounds 
 
HIGHLY TOXIC COMPOUNDS: 
Signal word: DANGER, (LD 50 <50mg/kg) 
 
THALLIUM:- 
      Physical nature:        white colour, crystalline in nature, odourless and  
                                           Tasteless. 
       Mechanism (41)   :      it combines with mitochondrial sulphydryl groups and  
                                     Thus interfering with the oxidative phosphorylation of   
                                     Respiratory chain 
      Fatal dose        :       14 mg/kg. 
      Volume of distribution  : 3.6 L/kg in humans  ;  20 L/kg in rats 
      Half life           : 2 to 15 days (40)    
       
 Clinical symptoms & signs: anorexia, abdominal pain, loose stools ,  
                                                   Delirium, coma, seizures, later symptom 
26 
                                                   Of  alopecia. 
      Onset of symptoms:  gastrointestinal symptoms develop immediately after  
                                        
                                            Ingestion, but other symptoms may develop after 
                                             12 hours. 
     Antidote    : activated charcoal and ferrocyanides .      
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FLOUROACETATE:- 
      
       Physical nature:     White colour, crystalline in nature, odourless and 
                                   Tasteless, water soluble 
       Mechanism     :  i) flouroacetate gets converted to flourocitrate , which  
                                Interfers with kreb’s cycle (42)   
                                    ii ) sodium flouroacetamide 
      Fatal dose          : i) flouroacetate   :-  3- 7 mg / kg 
                                  ii) sodium flouroacetamide  :-  13-14 mg /kg 
       Clinical signs& symptoms: seizures, tachycardia – mainly ventricular 
                                                   and coma 
       Onset of symptoms   : 2 to 20 hours  
       Prognostic indicators    : hypotension, increased creatinine level and  
                                              acidosis, may lead to death  , hypotension is due 
                                              to decreased  systemic vascular resistance and  
                                              increased cardiac output . 
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    Antidote     : i) no specific antidote 
                       ii) activated charcoal and sorbitol are recommended . 
                       iii) 500 ml of 10% acetamide in 5% dextrose over 30 mins every               
                           4 hours or 10% ethyl alcohol solution are used with limited  
                            Success (43) .   
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                              STRYCHININE:- 
      
     Physical nature           : bitter in taste                                                                                      
     Mechanism of toxicity: competitive antagonist for glycine at post synaptic      
                                        Spinal motor neuron (44) . 
      Fatal dose                 : for children – 15 mg (45)  . 
                                        for adults  - 1-2 mg/kg . 
    Volume of distribution: 13L/ kg  
    Clinical signs and symptoms   : anxiety, restlessness, hyperextended     
                                  posture, locked jaw, risus sardonicus , dysphagia. 
      Onset of action        : 10 to 20 minutes. 
       Antidote and treatment:  quiet room,  
                                               Intravenous benzodiazepines and  
                                                Neuromuscular  blockade drugs.  
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                                       ARSENIC TRIOXIDE 
  
    Physical nature            :  White colour , crystalline in nature . 
    Mechanism of toxicity :  it combines with sulphydryl groups and thus 
                                          Interfers with various  enzymatic actions. 
     Fatal dose                  : 1- 4 mg/kg  
     Clinical signs and symptom: difficulty in swallowing , nausea , vomiting , 
                                                   Bloody diarrohea , cardiac collapse and  
                                                    Altered  sensorium . 
    Onset of action          :  for symptoms - 1 hour.  
                                      For death         :  maximum of 24 hours.  
    Antidote                 :  i) succimer and dimercaprol (46) until urine arsenic 
                                       Level is less than 50 microgram in 24 hours. 
                                      ii) haemodialysis. 
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                                 BARIUM  
            ( available in soluble form as carbonate , chloride ) 
      Physical nature            : yellow colour, lustrous lump. 
      Mechanism of toxicity:  hypokalemia       and  
                                            Neuromuscular  blockade. 
      Fatal dose                     : 20-30 mg/kg. 
      Clinical symptoms & signs: headache, paraesthesia , paralysis , nausea ,  
                                                  Vomiting, loose stools, ECG changes as  
                                                   Arrhythmias and cardiac failure  
      Onset of action              : 1-8 hours 
       Antidote                       : i) orogastric lavage with sodium sulphate (47)      
                                             ii) potassium supplementation . 
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                    N-3- Pyridyl methyl –N`-p-Nitro-phenyl Urea (PNU) 
 
    Physical nature            : yellow colour, like yellow-green powder in bait. 
    Mechanism of toxicity   : Interfers with nicotinamide metabolism in pancreas  
                                          and destroys beta cells (48) , nervous system  
                                           and heart.  
   Fatal dose                      : 5 mg/kg. 
   Clinical signs & symptoms: vomiting with abdominal pain, severe 
                                                Orthostatic hypotension, hyperglycaemia (49) , 
                                                Neuropathy and  pneumonia. 
    Onset of action                 : maximum of 2 days. 
    Antidote                           : i) Nicotinamide 500 mg IV – loading dose and  
                                             Then titrate, according to toxicity. 
                                             ii) Manage hyperglycaemia with insulin . 
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                                  MODERATELY TOXIC COMPOUNDS 
 Signal word:  WARNING (LD 50 - 50 to 500 mg/kg) 
                        ALPHA – NAPHTHYL THIO UREA (ANTU) 
 
Physical nature       :  odourless, slightly bitter in taste, fine – gray powder,  
                                 insoluble in water. 
Mechanism of toxicity:   acute lung injury(50) . 
Clinical symptoms and signs:  breathing difficulty, rales , froth , cyanosis , 
                                                hypothermia. 
Onset of action   : not estimated.  
 Antidote            : only supportive care.  
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                               CHOLECALCIFEROL (VITAMIN D3) 
  
Physical nature         :  as various sized pellets.  
Mechanism of toxicity:   hyper calcemia. 
 Fatal dose               :  not estimated  
Clinical symptoms and signs: headache, lethargy, weakness, renal failure, 
                                              metastatic calcification. 
Onset of action         : hours to days.  
Antidote                  : i) fluid balance.     
                                ii) frusemide, prednisolone , calcitonin , biphosphates . 
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                        LOW TOXICITY COMPOUNDS  
Signal word   :-  CAUTION  ( LD 50 , 500 to 5000 mg/kg  ) 
 
RED SQUILL  
     Physical nature     : bitter taste  
    Mechanism of toxicity:  as cardiac glycoside (51) . 
    Onset of action        :  30 minutes to 6 hours.  
    Fatal dose             :  not estimated. 
    Clinical symptoms & signs:  myocardial irritability, blurred vision, 
                                                  Hyperkalemia. 
    Antidote                  :  digoxin specific antibodies, atropine.  
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             NORBROMIDE   
  
Physical nature             :  yellow cornmeal bait; 
                                       peanut butter. 
 Mechanism of toxicity: vasoconstriction and ischaemia in rats through specific  
                                     smooth muscle receptors.  
 Clinical symptoms and signs: transient hypothermia and hypotension52) . 
 Fatal dose and onset of action: not estimated. 
  Antidote    :  only supportive care. 
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                           BROMETHALIN 
 
 Physical nature              : 7.5% concentrate pellets. 
Mechanism of toxicity     : uncouples oxidative phosphorylation (53) , 
                                         Interrupts nerve conduction. 
 Clinical symptoms and signs: muscle tremor, myoclonic jerks,  
                                              ataxia, coma, focal seizures. 
 Immediate onset of action .  
     Only supportive care . 
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                       SHORT ACTING ANTICOAGULANTS  
   WARFARIN & PROLIN: 
        Physical nature         : yellow cornmeal or rolled oats. 
        Mechanism of toxicity: warfarin – anticoagulation by vitamin k dependent       
                                            Factors (ii,vii, ix ,x ); death due to haemorrhage. 
                                            Prolin  - combines with antibiotic and eliminates  
                                            intestinal organisms that produce vitamin k. 
        Signs                   : bleeding with elevated INR values.  
         Onset of action     : 12 to 48 hours.  
         Antidote               :  vitamin k1 and fresh frozen plasma (FFP). 
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              OTHER LONG ACTING ANTICOAGULANTS  
   INDANDIONES: 
             Pindone, Pivalyn, Valone, Diphacinone.  
        Physical nature    : mouldy, fluffy yellow powder. 
        Mechanism of toxicity: anticoagulant.  
         Onset of action     : several days.  
         Clinical symptoms & signs:  chronic ingestion produces cardiac and  
                                                     Cardiac and neurological symptoms,  
                                                     along bleeding with elevated INR. 
        Antidote         : vitamin k1 and FFP. 
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MATERIALS AND METHODS:- 
 
This study was conducted at Thanjavur medical college, Thanjavur , during the 
period of January 2012 to November 2012 . There were 108 patients admitted 
with alleged history of ingesting rodenticide compound in our emergency 
medical ward during the study period. After applying, the inclusion and 
exclusion criterias , 60 patients only fulfilled all the criteria and they were 
chosen as study subjects  (n =60 ). 
                Inclusion criteria:- 
          1.  Patient ingesting rodenticide (bait, paste or powder) immediately 
before admission, maximum period of within 24 hours. 
                Exclusion criteria:- 
1. Patient treated outside and referred to our hospital. 
2. Patient presenting after 24 hours of ingestion. 
3. Patient consuming the poison along with alcohol or other compounds. 
4. History of chronic alcoholism or jaundice in the recent past. 
5. Suffering from any other serious systemic diseases. 
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  Method of collection of datas:- 
                Patient admitted in emergency medical ward with history of 
ingesting rodenticide compound were taken as study subjects. A complete 
history, clinical examination of toxicity of individual compounds and 
certain relevant biochemical investigations were performed .patients 
fitting into the inclusion criteria as described by the patients or 
identification of rodenticide compound. 
               After obtaining complete history, a complete clinical 
examination was performed, with particular importance to the vitals, 
jaundice, bleeding manifestations, as explained in the proforma. This 
evaluation was done in our emergency ward. Patient was further followed 
till their stay in hospital, they are noticed for development of jaundice or 
further prognosis of the patient and relevant investigation datas are 
collected. 
                 Importance to jaundice , bleeding tendencies , oliguria and 
seizures or headache , serum bilirubin value on admission , on 4 th day 
and afterwards , INR value , serum creatinine and SGOT value on 4 th 
day were collected . 
                 All patients were managed with usual decontamination method 
including nasogastric lavage and treated according to nature of compound 
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with intramuscular vitamin k and laxatives. inj N-acetyl cystiene was tried 
in intensive care unit . 
           Counselling was given to the survivors. 
            Autopsy was done for all expired patients. 
Statistical tests:- 
          Chi square test and one way ANOVA ‘f’ test were used in this 
study. 
              Ethical committee clearance was obtained before commencing 
the study. 
              Informed consent is obtained either from patients or their 
relatives. 
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         RESULTS 
 
FIGURE 1 :     AGE DISTRIBUTION  
 
TABLE  1 : 
 
            
 
 
 
     Patients are most common in 20 – 30 years of age group. 
 
 
 
0
5
10
15
20
25
30
35
< 20 YRS 20 TO 30 YRS > 30 YRS
NUMBER OF PATIENTS(60)
     AGE (YRS ) NO OF 
PATIENTS(60) 
    LESS THAN 20       14 
     20 TO  30        33 
     MORE THAN 30        13 
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FIGURE 2: SEX DISTRIBUTION
                                                                                                                      
                     MALE           
                     FEMALE  
 
 
 
 
 
 
- 36 PATIENTS ( 60% )  
- 24 PATIENTS ( 40% )                                                                
NUMBER OF PATIENTS(60)
 
MALE
FEMALE
  
FIGURE 3:   ACCORDING TO SOCIO
 
 
LOWER SOCIO
MIDDLE SOCIO
HIGHER SOCIOECONOMIC STATUS :
 
 
-ECONOMIC STATUS :
-ECONOMIC STATUS :-  47 Patients  (78.3% )
-ECONOMIC STATUS :-  13 Patients  (21.7%)
-   0 Patients  (0%)
NUMBER OF PATIENTS (60)
- 
 
 
 
 
LOWER
MIDDLE
HIGHER
  
FIGURE 4 :       
 
MARRIED PERSONS :
UNMARRIED PERSONS :
 
 
 
 
MARITAL STATUS OF THE PATIENT :
-  26  (43.3%) 
-  34  (56.7%) 
NUMBER OF PATIENTS(60)
- 
 
MARRIED
SINGLE
  
FIGURE 5 :       
 
 
BAIT                :
PASTE             :
POWDER        :
 
QUALITY OF INGESTED POISON :-
- 7 Patients ( 11.7% ) 
- 42 Patients (70.0% ) 
- 11 Patients ( 18.3% ) 
NUMBER OF PATIENTS(60)
 
 
BAIT
PASTE
POWDER
 FIGURE 6:    QUANTITY OF POISON CONSUMED :- 
 
  
5 gms             :- 18 patients (30.0%) 
10 gms           :- 17 patients (28.3%) 
15 gms           :- 12 patients (20.0%) 
20gms            :- 9 patients (15.0%) 
25gms           :- 3 patients (5.0%) 
30gms            :-1 patients (1.7%) 
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 FIGURE 7 :       
INGESTION TO 
   
   
BELOW 4 HRS                    :
4 TO 8 HRS                          :
ABOVE 8 HRS                    :
 
 
TIME DELAY OF PATIENT FROM 
HOSPITALISATION : 
- 29 (48.3%) 
- 22 (36.7%) 
- 9 (15%) 
number of patients(60)
 
BELOW 4 hrs
4-8 hrs
ABOVE 8 hrs
 CLINICAL MANIFESTATIONS :
            FIGURE 8 :     Comparison of symptomatology 
           Thus commonest symptom is abd
(90%) , followed by vomiting which is found in 29 patients (48.3%) , next being 
diarrhoea which is observed in 22 patients (36.7%) . however jaundice is 
observed in 12 patients , still mortality is observed in all pati
(100%) . 
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          FIGURE 9 :     JAUNDICE DEVELOPED AFTER ADMISSION
Patient developing jaundice after admission , mostly on 3
   Of the patients , were ingested paste ( phosphorus ) and every patient was
expired soon . this explains the main cause of death and also 
The most dangerous compound . 
           YES     :   12  ( 20.0% )
           NO       :    48 ( 80.0% )
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               FIGURE 10 :      BLEEDING MANIFESTATIONS :
Patients developing bleeding manifestations after ingesting poison ,
Of 7 pts with bleeding , 5 had consumed bait ( hydroxyl coumarins ) and other 
two consumed paste ( phosphorus ) probably due to acute hepatic toxicity . 
patients in bait group , had recovered after inj vit k fo
             Yes      :  7  ( 11.7% )
             No        :  53 ( 88.3% )
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                     FIGURE 11 :      
 
            Of 10 patients develop oliguria after admission , all of them belongs 
 To paste ( phosphorus ) group ,
That toxicity was also due to renal injury
            YES         :   10 ( 16.7% )
             NO         :    50 ( 83.3% )
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                       FIGURE 12 :     
 
               Only 4 patients had developed headache , no other neurological 
complications , all 4 belongs to paste (phosphorus ) group , and all of 
4 patients had expired . 
              YES           :  4 ( 6.7% )
              NO            :   56 ( 93.3 % )
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                FIGURE 13 :     SERUM BILIRUBIN LEVEL ON 4
 
             By estimating  serum bilirubin level on 4
patients showed bilirubin more than 1.5 mg , almost all of them had ingested 
Paste ( phosphorus ) . out of whi
           LESS THAN 1.5 mg  : 37 (61.7% )
          ABOVE  1.5 mg         : 23 (38.3% 
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                 FIGURE 14 :    SG
              Of total 60 patients , 24 patients showed SG
Normal value (40iu/l ) , which almost identical with elevated bilurubin level . 
12 patients had values more than five to ten times normal value , indicates acute 
Hepatocellular failure , it carries  almost 100% mortality .
             LESS THAN 40IU/L    :  36 (60%)
             40 TO 80  IU/L             :  11  (18.5%)
            MORE THAN 80IU/L  :  13  (21.5%)
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                FIGURE 15 :  SERUM CREATININE VALUE OF THE PATIENTS
 
                       Of total patients , 12 patients 
 Values , which indicates the renal toxicity of the phosphorus poison , which 
 Also carries the worse prognosis . 
               LESS THAN 1.2 mg /dl   :  48  ( 80% )
              1.3 TO 2  mg/dl                 :   8   
              MORE THAN 2 mg/dl     :   4   ( 6.7 % )
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                      FIGURE 16 :      
 
 
                               Of 60 patients got admitted , 12 patients had expired, all of 
  Them had consumed paste ( ph
poison .  
                    DEATH          :  12  ( 20 % )
                    RECOVERY  :  48   ( 80 % )
 
NUMBER OF PATIENTS(60)
RECOVERY OF THE PATIENT 
osphorus ) , thus indicating the lethal  mode of 
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FIGURE 17 :       AGE DISTRIBUTION COMPARED WITH MORTALITY :
TABLE 2 : 
AGE GROUP 
( YEARS ) 
 
DEATH (100%)
BELOW 20 2 (16.7%)
21 TO 30 7  (58.3%)
ABOVE 31 3  (25% )
 
 
0
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15
20
25
30
35
below 20 yrs 21 to 30 yrs
 
 
RECOVERY(100%) 
 
TOTAL(100%)
 12   (25%) 14  (23.3%)
 26   (54.2%) 33   (55%)
 10   (20.8%) 13   (21.7%)
31 yrs and above
death
recovery
total
 
 
 
 
 
 
   FIGURE 18 :     SEX DISTRIBUTION WITH MORTALITY :
 
TABLE 3 : 
       SEX      DEATH
       MALE            6 (50%)
      FEMALE            6 (50%)
 
          THUS FEMALE AND MALE PATIENTS HAVE EQUAL 
MORTALITY , HOWEVER MALE GOT MORE 
FEMALE 
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     RECOVERY       TOTAL
         30 (62.5%)        36 (60%)
         18 (37.5%)        24 (40%)
ADMISSION THAN 
FEMALE
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FIGURE 19 :    SOCIO-ECONOMIC STATUS WITH MORTALITY
 
TABLE 4 : 
SOCIO-
ECONOMIC 
      DEATH
      LOWER        10 (83.3%)
     MIDDLE         2 (16.7%)
 
                          BOTH  INCIDENCE AND MORTALITY WAS 
COMMONER IN PATIENTS FROM LOW COCIO
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FIGURE 20 :     MARITAL STATUS COMPARED WITH MORTALITY:
 
 
TABLE  5 : 
MARITAL 
STATUS 
 
       DEATH
MARRIED       6  (50%)
UNMARRIED       6  (50%)
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  RECOVERY 
 
      TOTAL
       20  (41.7%)       26 (43.3%)
       28  (58.3%)       34 (56.7%)
UNMARRIED
DEATH
RECOVERY
TOTAL
 
 
 
 
 
  
FIGURE 21 :      QUALITY OF THE POISON WITH MORTALITY :
  
TABLE 6: 
     QUALITY        DEATH
         BAIT      0   (    0%)
     PASTE     12  (100%)
     POWDER       0  (    0%)
 
Mortality is only with phosphorus compound ( paste ).
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      RECOVERY       TOTAL
        7  (14.6%)      7  (11.7%)
      30  (62.5%)     42  (70 %)
      11  (22.9%)      11  (18.3%)
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     FIGURE 22 :     TIME DELAY WITH MORTALITY :
 
TABLE 7 : 
  TIME DELAY  
               (hrs)               
      DEATH
     BELOW  4        1  (  8.3%)
        4 TO  8        4  (33
    ABOVE  8       7  ( 58.3%)
 
More time delay causes comparitevely more mortality .
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        RECOVERY        TOTAL
       28  ( 58.3% )      29  (48.3% )   
.3%)       18  ( 37.5% )      22  (36.7% )
         2  (   4.2%)       9  ( 15.0%)
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DEATH 
RECOVERY
TOTAL
 
 
 
 
 
  
FIGURE 23 :     JAUNDICE COMPARED WITH MORTALITY :
  
 TABLE  8 :  
   JAUNDICE     DEATH
           NO         0   (    0  %)
         YES       12   ( 100%)
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     RECOVERY         TOTAL
         47  ( 97.9 %)           47   (78.4%)
           1  (   2.1%)          13  ( 21.6%)
YES
DEATH
RECOVERY
TOTAL
 
 
 
 
  
        FIGURE 24 :     OLIGURIA WITH MORTALITY  :
 
  
TABLE  9: 
     OLIGURIA        DEATH
            NO       3  ( 25  % )
            YES       9   ( 75  % )
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       RECOVERY        DEATH
       47  ( 97.9% )       50  ( 83.3%)
         1   (   2.1%)       10  ( 16.7%)
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TOTAL
 
 
 
 
  
 FIGURE 25 :        SERUM BILURUBIN
COMPARED WITH MORTALITY 
                                                                            
TABLE 10 : 
SERUM 
BILIRUBIN 
(mg/dl) 
       DEATH  
  LESS THAN 1.5           0   (    0.0%)
   ABOVE 1.5      12  ( 100.0%)
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     RECOVERY       TOTAL
      37   ( 77.1%)       37 (61.7% )   
      11  ( 22.9%)       23 (38.3% )
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        FIGURE 26 :     SGPT LEVEL COMPARED WITH MORTALITY  :
 
TABLE 11: 
    SGPT (iu/l)       DEATH
 LESS THAN 40         0  ( 
  41 TO 80        0 (      0.0% )
 MORE THAN 81      12 ( 100.0% )
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       11   ( 23.5 % )        11 (18.3%)
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FIGURE 27 :     SERUM CREATININE LEVEL COMPARED WITH 
MORTALITY : 
  
TABLE 12 : 
SERUM 
CREATININE(mg/dl) 
    DEATH
LESS THAN 1.2      3  ( 25 % )
    1.3 TO 2.0      6  ( 50 % )
 MORE THAN 2.1      3  ( 25 % )
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       2  (   4.2 %)        8 ( 13.3% )
       1  (   2.1 %)        4 (  6.7% )
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DISCUSSION: 
                             This present study is a prospective longitudinal study 
conducted among 60 in-patients.         
                            This present study was conducted at Thanjavur medical 
college from January 2012 to November 2012, total of 60 cases were studied. 
rodenticide being the second most common poisoning in our area , only few 
studies were available , hence the clinical profile of the patients were described. 
Age: 
                 In this study , most number of the patient were in the age group of 21 
to 30 yrs (55%), of less than 30 yrs being 78.3%. maximum number of patients 
was 21 to 30 years as compared with p.s Shankar et al(55) and doshi et al(54) 
study. 
    Age Present study (%)  Doshi et al (%)   Shankar et al(%) 
   < 20 yrs       23.3         -          25  
21 – 30 yrs        55       44.44          60 
> 31yrs       21.7        -          15 
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Sex: 
             In this study, there was male preponderance (60%) , whereas female 
was 40% , with male : female ratio of 1.5:1 . this corresponds to sex distribution 
of Shankar et al and prakash et al(55). 
          Sex  Present study (%)  Shankar et al (%)  Prakash et al (%) 
       Male          60         59.8            60 
     Female         40         40.2             40         
 Male:female       1.5:1     1.48:1        1.5:1 
 
Marital status:- 
                In this study, majority of the patients were unmarried being 34 
patients (56.7%), while married patients being 26 (43.3%). 
Socio-economic status:- 
            In this study, patients from lower socioeconomic status form 78.3%, 
while from middle class forms 21.7%. When compared with chatterjee et al (56) 
and a goel et al (57)  . 
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     income  Present study (%) Chatterjee et l(%)  A goel et al (%) 
        Low        78.3          88          75.73 
      middle        21.7           11          24.27 
        High          -             1             - 
 
 
Quality (type) of poison ingested:- 
                  In this study, majority of the patients – 42 (70%) were ingested 
paste (phosphorus compound) , next comes powder - 11(18.3%) followed by 
bait ( super warfarins ) – 7 (11.7%).  
          quality       Present study (%)    Vijayasekar et al (%) 
  Phosphorus & 
phosphide compounds 
            88.3           69 
      superwarfarin              11.7            31 
 
Quantity of poison ingested:- 
                      In this study, patient ingested less than 10 g of 35 patients 
(58.3%), majority being phosphorus compound . 15 to 20 g being 21 patients 
(35%) and more than 20 g is 4 patients (6.7%) , major being powder (phosphide 
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compound) . even if quantity of poison ingested is less in phosphorus compound 
, it produces more mortality than other compound , since it is lethal even at dose 
of 1 mg / kg . 
   Time interval between ingestion and hospitalisation:- 
            In this study, it was observed that mortality was higher (91.6%), who 
had admitted after 4 hours of ingestion, as compared to mortality in patients 
admitted within 4 hours, which was only meagre (8.3%). This was compared 
with a goel et al study. 
 duration    Present study 
  
  A goel et al 
 
Patients(%)  Death (%) Patients(%) Death (%) 
< 4 hrs      48.3      8.3     14.5    20 
 4 – 8 hrs      36.7      33.3     54.4    28.57 
>8 hrs      15.0       58.3      31.1    53.12 
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 Clinical manifestations:- 
                     In this study , the most common symptom was abdominal pain 
observed in 90 % of the patients , followed by vomiting (48.3%) , next by 
diarrhoea (36.7% ) and thirst (33.3%) . however jaundice is observed only in 13  
patients (21.5%), but mortality is higher . 
Biochemical analysis:- 
                In this study, 23 patients (38.3%- almost all ingested phosphorus 
compound) showed elevated serum bilirubin on 4th day of more than 1.5 mg, out 
of which 12 patients (52.2%) had expired, which also correlate with elevated 
SGPT values measured on 4th day; indicating the acute hepatocellular toxicity of 
the phosphorus compound, measuring more than five times the normal value of 
SGPT. 
                    Serum creatinine was also elevated in 12 patients ingesting 
phosphorus compound. 
    Age distribution with mortality:- 
                  In this study there was no significant difference in both incidence 
and mortality in age groups of the patients. 
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 Sex distribution with mortality:- 
               In comparison to ingestion, however mortality in both the sex was 
equal of six patients each (50%), which also did not show any significant 
differences. 
   Socio-economic distribution with mortality:- 
                   In this study, there was also no significant difference in both 
incidence and mortality in both lower and middle socio-economic status of the 
patients.  
 
Marital status with mortality:- 
                        In this study, there is no significant difference in mortality in 
both married and unmarried groups, both groups carrying equal mortality of 50 
% each. 
Quality of poison with mortality:- 
                   In this study, all the mortality were among the paste group          
( phosphorus compound ) , carrying 28.5% of mortality among ingested 
persons. While phosphide and warfarin group carries  nil mortality. 
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Jaundice on 4th day with mortality:- 
                     In this study, 13 patients (21.6%) presented with jaundice of 
which 12 patients (92.3%) were expired. only one patient recovered, who was 
been treated with N-acetyl cysteine from the day of admission, who had only 
survived among all the icteric patients. 
Serum bilirubin on 4th day with mortality:- 
                      In this study , 23 patients showed elevated bilirubin of more 
than 1.5 mg/dl , out of which 12 patients (52%) had expired , others (48%) show 
only mild increase , which on subsequent days decreased and patients improved.  
 
SGPT level with mortality:- 
                       In this study, 13 patients (28.5%) showed elevated SGPT value of 
more than 80 iu/ l, out of which 12 patients (92.3%) expired and one patient 
recovered. 11 patients (18.3%) showed values of 40 to 80 iu /l, and almost all 
(100%) recovered. thus SGPT value of more than five times normal along with 
elevated bilirubin and jaundice carries nearly full mortality. 
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Serum creatinine with mortality:-  
                   In this study, 12 patients (20%) showed elevated serum 
creatinine values, out of which 9 patients (75%) had expired, who also had 
oliguria . thus it is not of much significance as other parameters in determining 
the mortality . 
                          Thus out of 60 patients got admitted, 12 patients (20%) had 
expired, all of them had ingested paste – phosphorus compound. 
                        Chi square test shows , there was no significant association 
between age , sex , socio-economic status , marital status , abdominal pain , 
bleeding manifestation , duration of stay and outcome of of the patient , which 
shows calculate value greater than table value ( p > 0.05 ). 
                     But there was significant association between quality , quantity , 
time delay ,thirst , diarrhoea , jaundice , oliguria , head ache , serum bilurubin 
on 4th day , SGPT , creatinine value of the respondents and their outcomes . 
They show calculate value less than table value (p < 0.05). 
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 Oneway ANOVA difference between SGPT, bilurubin on admn, 4th day, 
>1 wk, INR, creatinine of the respondents and the quality of poison 
Sl.no Quality Mean S.D SS Df MS Statistical inference 
 on admn       
 
Between 
Groups   2.099 2 1.049 
F=6.774 
.002<0.05 
Significant 
 Bait (n=7) .9143 .21931    
 
Paste 
(n=42) 1.3357 .44657    
 
Powder 
(n=11) .9364 .19117    
 
Within 
Groups   8.830 57 .155 
 4th day       
 
Between 
Groups   45.862 2 22.931 
F=6.184 
.004<0.05 
Significant 
 Bait (n=7) .9429 .26992    
 
Paste 
(n=42) 2.5310 2.25318    
 
Powder 
(n=11) .4545 .52795    
 
Within 
Groups   211.374 57 3.708 
 >1 wk       
 Between   37.338 2 18.669 F=3.491 
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Groups .037<0.05 
Significant 
 Bait (n=7) .0000 .00000    
 
Paste 
(n=42) 1.7214 2.72661    
 
Powder 
(n=11) .0000 .00000    
 
Within 
Groups   304.811 57 5.348 
 INR       
 
Between 
Groups   4.164 2 2.082 
F=5.732 
.005<0.05 
Significant 
 Bait (n=7) 2.1914 .55364    
 
Paste 
(n=42) 1.5493 .67715    
 
Powder 
(n=11) 1.2073 .08063    
 
Within 
Groups   20.704 57 .363 
 SGPT       
 
Between 
Groups   47.111 2 29.055 
F=6.050 
0.04<0.05 
 Significant 
 Bait (n=7) 0.9129 0.35336    
 
Paste 
(n=42) 2.6190 2.14607    
 
Powder 
(n=11) 0.4545 0.5323    
 
Within 
Groups   213.489 57 3.623 
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 creatinine       
 
Between 
Groups   1.469 2 .734 
F=2.609 
.082<0.05 
Significant 
 Bait (n=7) .9429 .69488    
 
Paste 
(n=42) 1.1286 .55887    
 
Powder 
(n=11) .7273 .18488    
 
Within 
Groups   16.045 57 .281 
Statistical test: Oneway ANOVA ‘f’ test was used the above table  
Inference: 
The above table indicates that there is a significant difference between bilurubin 
on admn, 4th day,  >1 wk, sgot, INR, creatinine of the respondents and their 
quality. Hence the calculate value less than table value (p<0.05). 
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                                               CONCLUSION:-   
   1)  Rodenticide poisoning is the second most common poisoning in our area. 
  2)  Male to female ratio in our study is 1.5: 1. 
3) Majority of the patients were in 20 to 30 years age group. 
4) Many of them are from low socioeconomic status. 
5) Phosphorus compound (paste) forms the major share of poison. 
6) Most common symptom is abdominal pain (90%). 
7) Bleeding manifestation is common in warfarin group (bait). 
8) Mortality in this study was 20 %. 
9) Increased time delay in hospitalisation carries more mortality. 
10) Mortality is seen only in phosphorus compound. 
11) Jaundice develop following ingestion of phosphorus, carries most mortality, 
which also correlates with elevated serum bilirubin and SGPT level. 
12) N-acetyl cysteine can be tried in early stages of hepatotoxicity . 
13) Phosphorus (paste) compound of rodenticide , must be banned , to prevent 
mortality in young productive  poor patients , who intend to ingest poison in a 
minute decision .                                                                               
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                              ANNEXURE I: 
 
 
        ABBREVATIONS  :- 
        
1. ALT       :  ALanine Transaminase (or) ALanine Aminotransferase. 
2. ANTU    :  Alpha – Naphthyl Thio Urea. 
3. DIC        :  Disseminated Intravascular Coagulation. 
4. ECG       :  Electro CardioGram. 
5. FFP        :  Fresh Frozen Plasma. 
6. GIT        :  Gastro Intestinal Tract. 
7. INR        :  Internatinational Normalized Ratio. 
8. LD 50     :  Lethal Dose in 50% of individuals. 
9. ppm        :  parts per million. 
10. PT         :  Prothrombin Time. 
11. SGPT    :  Serum Glutamic Pyruvic Transaminase. 
 
  
        
 
 
 
                                                                                                                                                    
 
                                                                                 
PROFORMA 
                                          
       NAME      : 
       AGE          : 
       SEX          : 
       ADDRESS  : 
       IP No        : 
       DOA         : 
       SOCIO-ECONOMIC STATUS  : lower/middle/upper 
       HISTORY  : 
              Informer :  patient/ relative 
              Quality of the compound  : bait/paste/powder 
              Quantity consumed   :          g 
              Whether taken with alcohol : yes/no 
              Time interval from ingestion to hospitalisation  :        hrs 
              Cause of  poisoning   : suicidal / accidental 
               Associated evidences     
                        Container     : 
                        Specific colour of vomitus : 
                        Gastric lavage     :  colour / smell 
                        Staining in body parts or dress: 
             Symptoms presented:  
1) Vomiting  : 
2) Abdominal pain : 
3) Loose stools   :  
4) Yellow coloured secretions : 
5) Decreased urine output  : 
6) Bleeding tendencies   : 
7) CNS    : headache/ seizures/coma 
          Past history:  
                    Consumed poison before   : yes/no 
                    Any serious illness   : yes/no 
                    Known psychiatric illness : yes/no 
                    Jaundice earlier   :  yes/no 
                    Known liver disease  : yes/no 
                    Known alcoholic    : yes/no 
                  Treated and referred from other hospitals:yes /no 
  GENERAL EXAMINATION : 
                   Conscious   : 
                   Icterus   : 
                   Vitals     pulse  : 
                                  BP        : 
SYSTEMIC EXAMINATION : 
                  CVS    : 
                  RS     : 
                 ABDOMEN  : 
                  CNS   :  
LAB INVESTIGATIONS  
          RBS   : 
UREA  : 
SERUM CREATININE   : 
SERUM ELECTROLYTES  : 
LIVER FUNCTION TESTS 
                      Bilirubin     Total   : 
                                          Indirect : 
                                          Direct : 
                       SGOT   : 
                      SGPT   : 
                      ALP    : 
                      Protein   : 
                      PT    : 
                      INR    : 
OUTCOME     :   
 
 
 
 
 
 
 
 
. 
 
  
                                ANNEXUREIII:                                                                                   
KEY TO MASTER CHART : 
1) s.no              : serial number 
2) i.p no           : inpatient number. 
3) On admn      : on admission. 
4) 4th day          : on fourth day. 
5) > 1 wk          : more than one week. 
6) INR              : International Normalised Ratio. 
7) Sgpt              : serum glutamic pyruvic transaminase . 
8) R                   : Recovery. 
9) D                   : Death . 
10) m                 : male . 
11) f                   : female . 
12) l                    : low socio-economic status. 
13) m                  : middle  socio-economic status. 
14) s                    : single. 
15) m                  : married . 
16) 0                    : no symptoms. 
17)  1                   : presence of symptoms. 
  
              ANNEXURE II : 
                     KEY TO PROFORMA : 
1) I p no                  : inpatient number . 
2) DOA                   : Date Of Admission . 
3) CNS                    : Central Nervous System . 
4) BP                       : Blood Pressure . 
5) CVS                    : Cardio Vascular System . 
6)  RS                     : Respiratory System . 
7) RBS                   :  Random Blood Sugar . 
8) SGOT                 : Serum Glutamic ornithyl Transferase. 
9) SGPT                  : Serum Glutamic Pyruvic Transamnase 
10) PT                 : Prothrombin Time. 
11) INR               : International Normalised Ratio .   
           
     
                                                                                                                         
vo
m
iti
ng abdominal 
pain
thirst diarrhoea
1 senthil kumar 24 m 1372275 l s powder 20 g < 4 hrs 0 1 0 0
2 ramya 17 f 1373382 l s paste 5 g < 4 hrs o 1 0 0
3 boopathy 20 m 1374970 m s bait 5 g < 4 hrs 0 1 0 0
4 prakash 28 m 1377082 m m paste 20 g 4-8 hrs 1 1 0 1
5 loganathan 21 m 1377918 l s paste 10 g 4-8 hrs 1 1 0 1
6 ajith kumar 14 m 1378408 l s powder 15 g < 4 hrs 1 0 0 0
7 muthukumaran 30 m 1378861 m m paste 5 g < 4 hrs 0 1 0 1
8 annamalai 22 m 1379467 l s paste 10 g > 8 hrs 1 1 1 1
9 joseph 58 m 1379572 l m bait 10 g 4-8 hrs 0 1 1 0
10 rasiya 30 f 1382582 l m paste 15 g < 4 hrs 0 1 0 1
11 sagayaraj 27 m 1381984 l m paste 5 g 4-8 hrs 1 1 0 0
12 raja 24 m 1382838 l s paste 10 g < 4 hrs 1 1 0 1
13 sivalingam 24 m 1383406 l s paste 15 g > 8 hrs 1 1 1 1
14 karthika 21 f 1383916 m s powder 25 g < 4 hrs 0 1 0 1
15 vadivel 55 m 1385406 l m paste 5 g < 4 hrs 1 1 0 0
16 muthumani 13 f 1387759 l s bait 5 g < 4 hrs 0 0 0 0
17 rajalakshmi 25 f 1388085 l m paste 20 g 4-8 hrs 1 1 1 1
18 gunasekaran 26 m 1389455 l s paste 10 g < 4 hrs 0 1 0 1
19 sakuntala 50 f 1389706 l m paste 20 g > 8 hrs 1 1 1 0
20 sambandam 36 m 1391199 m m paste 15 g 4-8 hrs 0 1 1 0
21 prabhudeva 18 m 1392061 l s paste 5 g < 4 hrs 1 1 0 0
22 rengasamy 75 m 1392544 l m paste 5 g < 4 hrs 0 1 0 0
23 deivakani 25 f 1392557 l m paste 5 g < 4 hrs 1 1 0 0
names.no
qu
al
ity
marital statusi.p nosex
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age
symptoms
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y
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e 
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vo
m
iti
ng abdominal 
pain
thirst diarrhoea
names.no
qu
al
ity
marital statusi.p nosex
socioecon
omic 
status
age
symptoms
qu
an
tit
y
tim
e 
de
la
y
24 aravindraj 23 m 1392606 l s powder 25 g 4-8 hrs 0 0 0 0
25 sakuntala 32 f 1393188 l m paste 15 g > 8 hrs 1 1 1 1
26 karthik 23 m 1395065 l s bait 5 g 4-8 hrs 0 1 1 0
27 kumaresan 19 m 1395852 l s paste 10 g < 4 hrs 0 1 0 0
28 mansur ali 18 m 1395916 m s powder 20 g > 8 hrs 0 1 0 0
29 kamala 39 f 1396530 l m paste 15 g < 4 hrs 0 1 1 1
30 vasuki 35 f 1398279 l m paste 5 g 4-8 hrs 0 1 1 0
31 sathyaraj 23 m 1398455 m s paste 15 g 4-8 hrs 1 1 1 0
32 paramanandham 28 m 1398513 l m powder 25 g < 4 hrs 0 1 1 0
33 ragavan 55 m 1398580 m m paste 5 g < 4 hrs 0 1 1 0
34 dinesh kumar 24 m 1398638 l s powder 20 g 4-8 hrs 0 1 0 0
35 shakila 17 f 1399142 l s paste 5 g < 4 hrs 0 1 0 1
36 karnan 40 m 1399461 l m paste 10 g 4-8 hrs 1 1 0 0
37 manibharathi 21 m 1400006 l s paste 5 g 4-8 hrs 1 1 1 1
38 nathiya 30 f 1400079 l m paste 10 g 4-8 hrs 1 1 0 0
39 saranya 20 f 1401321 m s bait 5 g < 4 hrs 0 1 1 0
40 sivakumar 14 m 1402557 l s paste 10 g 4-8 hrs 1 1 0 1
41 indirani 35 f 1403446 l m powder 30 g < 4 hrs 1 0 0 0
42 mahalakshmi 23 f 1403692 l m paste 5 g 4-8 hrs 0 1 1 0
43 revathi 20 f 1404255 l s paste 15 g > 8 hrs 1 1 1 0
44 sathya 27 f 1404690 m m paste 10 g > 8 hrs 0 1 0 1
45 amuthan 30 m 1404975 l s paste 10 g 4-8 hrs 1 1 0 0
46 abdullah 20 m 1405889 m s paste 10 g < 4 hrs 1 1 0 0
vo
m
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47 malathi 30 f 1407239 l m powder 20 g 4-8 hrs 0 0 0 0
48 madhavan 26 m 1407782 l s paste 10 g < 4 hrs 0 1 1 1
49 venkatesan 29 m 1408901 l s paste 20 g > 8 hrs 1 1 1 1
50 mangayarkarasi 27 f 1408945 l m paste 15 g > 8 hrs 1 1 0 1
51 vinotha 22 f 1409261 l m bait 10 g < 4 hrs 0 1 0 0
52 subashini 24 f 1409397 m s paste 15 g < 4 hrs 1 1 0 0
53 durgadevi 22 f 1410404 l s powder 20 g 4-8 hrs 1 1 0 0
54 valli 35 f 1412127 l m paste 10 g 4-8 hrs 0 1 0 1
55 siva 30 m 1412707 l s paste 15 g < 4 hrs 1 1 0 0
56 murugesan 40 m 1413384 l m paste 10 g < 4 hrs 0 1 0 1
57 kannan 26 m 1413820 l s powder 15 g < 4 hrs 0 0 0 0
58 tamil ilakiya 17 f 1414549 m s bait 5 g 4-8 hrs 1 1 0 0
59 ramesh 20 m 1415791 l s paste 5 g < 4 hrs 1 1 0 0
60 gopu 26 m 1416245 l s paste 10 g 4-8 hrs 0 1 1 1
1 senthil kumar
2 ramya
3 boopathy
4 prakash
5 loganathan
6 ajith kumar
7 muthukumaran
8 annamalai
9 joseph
10 rasiya
11 sagayaraj
12 raja
13 sivalingam
14 karthika
15 vadivel
16 muthumani
17 rajalakshmi
18 gunasekaran
19 sakuntala
20 sambandam
21 prabhudeva
22 rengasamy
23 deivakani
names.no
jaundice
bleeding 
manifestations
oliguria headache
on 
admn
4th 
day
>1 wk
0 0 0 0 1.2 _ _ 1.1 28 0.8 3 days R
0 0 0 0 1.1 1 _ 1.84 27 0.7 5 days R
0 1 0 0 0.8 1 _ 1.3 42 0.6 7 days R
1 0 1 0 1.4 3.2 7.6 2.3 344 2.4 8 days D
0 0 0 0 0.9 1.6 1.1 1.22 44 0.8 9 days R
0 0 0 0 0.7 1.1 _ 1.1 34 0.8 3 days R
0 0 0 0 1.4 1 _ 1.46 26 0.6 6 days R
1 0 1 1 1.6 3.8 6.3 1.3 278 2.5 7 days D
0 1 0 0 1.2 1.4 _ 2.34 29 0.7 5 days R
0 0 0 0 1.o 2.1 1.3 1.26 37 1.2 6 days R
0 0 0 0 0.9 1.7 1.3 1.2 34 0.9 8 days R
0 0 0 0 1.3 1.1 1.1 1.32 42 1 7 days R
1 0 1 1 3.4 12.4 _ 1.9 463 2 6 days D
0 0 0 0 0.9 1 _ 1.16 26 0.7 4 days R
0 0 0 0 1.6 1.3 _ 1.24 51 1.4 5 days R
0 0 0 0 0.7 0.6 _ 1.7 38 0.6 4 days R
1 0 1 0 1.7 4.8 _ 1.6 410 1.9 4 days D
0 0 0 0 1.2 1.7 1.6 1.3 52 0.9 8 days R
1 0 0 1 1.6 5.8 _ 1.9 374 1.8 4 days D
0 0 1 0 1 1.9 1.3 1.2 47 1 9 days R
0 0 0 0 1.2 0.8 _ 1.16 43 0.9 5 days R
0 0 0 0 1.2 1 _ 1.1 24 1.2 5 days R
0 0 0 0 1.2 1.4 _ 1.26 54 0.7 6 days R
INR Duration of stayal outcome
serum bilurubinsymptoms
sgpt
cr
ea
tin
in
e
names.no
24 aravindraj
25 sakuntala
26 karthik
27 kumaresan
28 mansur ali
29 kamala
30 vasuki
31 sathyaraj
32 paramanandham
33 ragavan
34 dinesh kumar
35 shakila
36 karnan
37 manibharathi
38 nathiya
39 saranya
40 sivakumar
41 indirani
42 mahalakshmi
43 revathi
44 sathya
45 amuthan
46 abdullah
jaundice
bleeding 
manifestations
oliguria headache
on 
admn
4th 
day
>1 wk
INR Duration of stayal outcome
serum bilurubinsymptoms
sgpt
cr
ea
tin
in
e
0 0 0 0 0.9 _ _ 1.24 26 0.6 3 days R
1 0 1 0 0.8 5.8 _ 2.8 285 2.7 5 days D
0 1 0 0 0.7 0.8 _ 2.3 32 0.6 4 days R
0 0 0 0 0.8 0.9 _ 1.2 22 0.7 6 days R
0 0 0 0 0.8 0.8 _ 1.2 26 0.5 5 days R
0 0 0 0 1.4 3 5.3 2.5 352 1.8 7 days D
0 0 0 0 1.4 1.2 _ 1.2 39 0.9 6 days R
1 0 1 0 1.2 4 6.2 1.3 242 1.9 8 days D
0 0 0 0 0.8 _ _ 1.12 37 0.7 3 days R
0 0 0 0 1.4 1.2 _ 1.2 42 0.9 6 days R
0 0 0 0 0.7 _ _ 1.3 32 0.7 3 days R
0 0 0 0 0.9 1.2 1 1.2 34 0.6 6 days R
0 0 0 0 1.3 1.8 1.4 1.1 46 1.2 7 days R
0 0 0 0 1.2 1.5 1.1 1.2 26 0.7 7 days R
0 0 0 0 1.6 1.4 _ 1.3 39 1 6 days R
0 0 0 0 1.2 1.1 _ 2.7 42 0.7 4 days R
1 1 0 0 1.2 3.7 6.4 1.9 176 0.9 7 days D
0 0 0 0 1 _ _ 1.2 32 0.6 2 days R
0 0 0 0 1.2 1 _ 1.14 24 0.6 5 days R
1 1 1 0 2.3 6.8 12 4.8 157 0.6 9 days D
0 0 0 0 0.8 1.6 1.2 1.4 36 0.7 8 days R
0 0 0 0 1.6 1.3 _ 1.3 31 0.6 5 days R
1 0 0 0 1.6 1.3 1 1.32 26 1.3 7 days R
names.no
47 malathi
48 madhavan
49 venkatesan
50 mangayarkarasi
51 vinotha
52 subashini
53 durgadevi
54 valli
55 siva
56 murugesan
57 kannan
58 tamil ilakiya
59 ramesh
60 gopu
jaundice
bleeding 
manifestations
oliguria headache
on 
admn
4th 
day
>1 wk
INR Duration of stayal outcome
serum bilurubinsymptoms
sgpt
cr
ea
tin
in
e
0 0 0 0 1.2 _ _ 1.24 25 1.2 3 days R
0 0 0 0 1.6 1.8 1.3 1.26 29 0.9 7 days R
1 0 1 1 1.4 5.8 _ 1.6 374 2.3 4 days D
1 1 1 0 1.2 5.2 7.3 2.8 317 2 6 days D
0 1 0 0 1 1 _ 2.1 28 0.7 4 days R
0 0 0 0 1.7 2.3 1.6 1.9 37 0.9 18 days R
0 0 0 0 1.2 1.1 _ 1.3 26 0.6 4 days R
0 0 0 0 1.3 1.7 1.4 1.24 36 0.7 8 days R
0 0 0 0 1.4 1.6 1.4 1.33 28 0.9 6 days R
0 0 0 0 1.2 1.4 1.1 1.25 29 1 6 days R
0 0 0 0 0.9 1 _ 1.32 32 0.8 4 days R
0 0 0 0 0.8 0.7 _ 2.9 24 0.9 4 days R
0 0 0 0 0.9 1.3 1 1.15 42 0.8 6 days R
0 0 0 0 1 0.9 _ 1.12 34 0.7 5 days R
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